ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 2 filers reported holding ASLAN PHARMACEUTICALS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,806,000 | +12.2% | 3,015,987 | -7.2% | 0.04% | 0.0% |
| Q2 2022 | $1,609,000 | -45.0% | 3,250,000 | 0.0% | 0.04% | -31.1% |
| Q1 2022 | $2,924,000 | -19.7% | 3,250,000 | 0.0% | 0.06% | +15.1% |
| Q4 2021 | $3,640,000 | -37.1% | 3,250,000 | 0.0% | 0.05% | -39.1% |
| Q3 2021 | $5,785,000 | -46.1% | 3,250,000 | 0.0% | 0.09% | -46.3% |
| Q2 2021 | $10,725,000 | -1.5% | 3,250,000 | 0.0% | 0.16% | -4.7% |
| Q1 2021 | $10,888,000 | – | 3,250,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 568,182 | $1,068,181 | 0.12% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |